Open
SectorHealthcare
8.39 3.84
24h
Min
8.06
Max
8.34
Income | -13M -27M |
---|---|
Sales | 14M 132M |
EPS | -0.13 |
Profit margin | -20.371 |
Employees | 580 |
EBITDA | -13M -1.2M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +85.05% upside |
Next Earnings | 5 maj 2025 |
---|
Market Cap | -155M 1.6B |
---|---|
Previous open | 4.55 |
Previous close | 8.39 |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 14.73 USD 85.05%
High 30 USD
Low 8 USD
Based on 11 Wall Street analysts offering 12 month price targets forBioCryst Pharmaceuticals Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$